Stealth Editor News Today

The once-promising Pittsburgh biotech firm that developed precision genetic medicines set a board vote for May 13.

New preclinical data validates that Stealth Editors™ are non-immunogenic, as featured in a poster presentation at the 28th American Peptide Symposium First non-human primate (NHP) study to successfully redose a gene editor without an immune r...